Session Details
Oral Presentation 8 : Vaccine development
Sat. Sep 27, 2025 3:20 PM - 4:10 PM JST
Sat. Sep 27, 2025 6:20 AM - 7:10 AM UTC
Sat. Sep 27, 2025 6:20 AM - 7:10 AM UTC
Room 5(2F Meeting Room 204)
Chair:Tadaki Suzuki, Minoru Kidokoro
[O8-01]ヒト肺サーファクタント由来粘膜アジュバントSF-10混合インフルエンザワクチン経口接種により誘導される防御免疫誘導は制御性T細胞の影響を受ける
*Takashi Kimoto1,2, Satoko Sakai2, Keiko Kameda2, Etsuhisa Takahashi2, Takako Sawabuchi2, Hiroshi Kido2 (1. KOBE GAKUIN Uni. Faculty of Pharmacy, 2. The Univ. of Tokushima The Inst. for Enz. Res.)
[O8-02]2025/26シーズン用季節性インフルエンザワクチン製造候補株の性状解析
*Yasushi Suzuki1, Tomoko Arita1, Eita Sasaki1, Ryuichi Sugiyama1, Yuichi Harada1, Hitoshi Takahashi1, Shinji Watanabe1, Hideki Hasegawa1, Hideki Asanuma1 (1. National Institute of Infectious Diseases Influenza Research Center)
[O8-03]Solubility-controlling peptide tag-mediated oligomers of a 12 kDa Japanese encephalitis virus envelope protein domain III generated neutralizing antibodies
*Md. Din Islam1, M. Monirul Islam2,3, Ayae Inoue1, Sanjida Yesmin1, Subbaian Brindha1,2, Takahiro Yoshizue1, Hiromichi Tsurui1,4, Takeshi Kurosu5, Yutaka Kuroda1,2 (1. Department of Biotechnology and Life Science, Faculty of Engineering, Tokyo University of Agriculture and Technology, Nakamachi 2-24-16, Tokyo 184-8588, Japan, 2. Institute of Global Innovation Research, Tokyo University of Agriculture and Technology, 3-8-1 Harumi-cho, Fuchu-shi, Tokyo 183-8538, Japan, 3. Department of Biochemistry and Molecular Biology, Faculty of Biological Sciences, University of Chittagong, Chittagong-4331, Bangladesh, 4. Department of Immunological Diagnosis, Juntendo University School of Medicine, Hongo 2-1-1, Tokyo 113-8421, Japan, 5. Department of Virology I, National Institute of Infectious Diseases, Musashimurayama, Gakuen 4-7-1, Tokyo 208-0011, Japan)
[O8-04]Evaluation of the Efficacy and Safety of a Modified Mumps Vaccine Candidate Strain and Exploration of a Novel Route of Administration in a Common Marmoset Model
*Minoru KIDOKORO1, Fumihiro Katoh1, Koji Ishii1 (1. Japan Institute for Health Security)
[O8-05]Sepivac SWETM: an open-access oil-in-water emulsion adjuvant for prophylactic vaccine applications
*Ko Sugahara1, Dorine Hello1, Hocine Nouari1 (1. SEPPIC SA)